In PC12 cells coincubated with H2O2, Scutellarein produced reported inhibiting rates of 94.92%, 35.32% and 4.57% at 100 μmol/L, 10 μmol/L and 1 μmol/L, respectively, relative to the H2O2 group. In AGS cells, Scutellarein had cell viability IC50 values of 62.88 μM at 24 h and 49.18 μM at 48 h. In HT1080 human fibrosarcoma cells, Scutellarein at 10 and 50 μm/l reduced cell viability by 27.6% and 32.8%, respectively, compared with DMSO-treated cells. [1,2,3]
Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.
Inhibiting rates in peroxide-exposed cells
Cell-based study · PC12 cells [1]
PC12 cells were coincubated with Scutellarein and H2O2 for 3 h. At Scutellarein concentrations of 100 μmol/L, 10 μmol/L and 1 μmol/L, reported inhibiting rates were 94.92%, 35.32% and 4.57%, respectively, relative to the H2O2 group.
Literature-Reported Treatment Conditions
- Treatment concentration
- 100 μmol/L; 10 μmol/L; 1 μmol/L
- Exposure duration
- 3 h with H2O2
- Method
- coincubation of PC12 cells with sample and H2O2
- Co-treatment
- Other interventions in this design: H2O2 400 μmol/L. Compound effect isolated by the comparison: A1 was the absorbance in the presence of sample and H2O2, A2 was the absorbance in the presence of H2O2 (model).
- Reported limits
- Not stated in the sentences used: vehicle.
Methods and source locations
Compound reported in the paper: Scutellarein
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
2. Materials and Methods > 2.6. MTT Assay for PC12 Cell Survival (S31, S34, S35, S37); Table 3 legend (S42); Table 3 (T3.h1, T3.h2, T3.r4, T3.r5, T3.r6)
Inhibiting Rate (%): Inhibiting Rate (%); comparator: H2O2 group — Table 3 (T3.h1, T3.h2, T3.r4, T3.r5, T3.r6)
Cell viability in AGS cells
Cell-based study · AGS [2]
AGS cells were treated with Scutellarein, with DMSO alone as the vehicle control. Cell viability IC50 values were 62.88 μM at 24 h and 49.18 μM at 48 h.
Literature-Reported Treatment Conditions
- Treatment concentration
- 25, 50, 75 and 100 μM
- Exposure duration
- 24 and 48 h
- Vehicle
- DMSO
- Reported limits
- Not stated in the sentences used: route.
Methods and source locations
Compound reported in the paper: Scutellarein
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
RESULTS > Scutellarein inhibited cell proliferation in AGS and SNU-484 gastric cancer cells (S1, S6); MATERIALS AND METHODS > Cell viability assay (S70, S71); Figure 1 legend (S117)
Cell viability: Cell viability; comparator: vehicle (DMSO) alone — RESULTS > Scutellarein inhibited cell proliferation in AGS and SNU-484 gastric cancer cells (S6); Figure 1 legend (S117)
Cell viability in human fibrosarcoma cells
Cell-based study · HT1080 human fibrosarcoma cells [3]
HT1080 human fibrosarcoma cells were treated with Scutellarein for 24 h. Concentrations of 10 and 50 μm/l reduced cell viability by 27.6% and 32.8%, respectively, compared with DMSO-treated cells.
Literature-Reported Treatment Conditions
- Treatment concentration
- 10 and 50 μm/l
- Exposure duration
- 24 h
- Method
- fresh medium containing 2 different concentrations (10 and 50 μm/l) of scutellarein
- Vehicle
- 10% dimethyl sulfoxide (DMSO)
Methods and source locations
Compound reported in the paper: Scutellarein
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Materials and methods > Drugs (S2); Materials and methods > Cell viability (MTT) assay (S13, S16); Results > Anti-proliferative effects of scutellarein against HT1080 fibrosarcoma cells (S86); Figure 1 legend (S131)
MTT assay (n=5): MTT assay (n=5); comparator: DMSO-treated cells — Results > Anti-proliferative effects of scutellarein against HT1080 fibrosarcoma cells (S86); Figure 1 legend (S131)